Clinical Trials Information System (CTIS): Walk-in clinic
EventHumanClinical trials
Date
- Monday, 04 April 2022, 16:00 (CEST) - 17:00 (CEST)
Location
- OnlineEuropean Medicines Agency, Amsterdam, the Netherlands
Event summary
Update: This event was cancelled due to technical issues. Please refer to the scheduled event on 22 April 2022: |
This walk-in clinic on CTIS functionalities provides an opportunity for sponsors to receive practical about the Clinical Trials Information System by asking questions to CTIS experts in real-time.
The CTIS experts will address all the questions related to system functionalities. Questions about the interpretation of the Clinical Trial Regulation and /or national processes are out of the scope of this event.
The event is open to all sponsor organisations, including pharmaceutical companies, contract research organisations, small and medium-sized enterprises (SMEs) and academic organisations. It will be live broadcast and no registration is required for those wishing to follow the live broadcast on EMA’s website.
In order to make the best out of this session, attendees are highly recommended to first consult the available online training and support materials:
- CTIS online modular training programme, including frequently asked questions (FAQs) per module
- CTIS Sponsor handbook
- CTIS Reference materials for clinical trial sponsors
EMA cannot provide attendees certificates of attendance for this event.
A video recording is made available after the event. Processing and publication of the video recording typically takes up to 60 days. Please subscribe to the Clinical Trials newsletter for updates on the availability of CTIS event video recordings. To subscribe, write to ct.newslettersubscriptions@ema.europa.eu.
Live participation via Slido
Throughout the meeting, participants will be able to ask questions or give their input via the audience interaction tool Slido. Once the event begins, please go to www.slido.com and enter the event code “#829652”.
Interaction via Slido is voluntary, and you may opt to remain anonymous. If you chose to use Slido, you consent to the processing of your personal data as explained in European Medicines Agency’s privacy statement for the use of audience interaction tool Slido.